Darin Feinstein, age 50, has served as Chief Vision Officer and Co-Chair of the Board of Core Scientific since January 2022. An entrepreneur active in the digital assets space since 2012, Feinstein co-founded Legacy Core in 2017 and founded Blockcap in 2020. Beyond these blockchain ventures, he owns and operates a diversified business portfolio spanning live entertainment, finance, food & beverage, hospitality, and technology.
Feinstein is a California-licensed attorney (currently non-practicing) and holds gaming licenses, liquor licenses, and various financial licenses in multiple states. He co-founded The Feinstein Griffin Foundation with comedian Eddie Griffin and has been involved in charitable events and donations over the past decade.
Biography extracted from Core Scientific DEF 14A filed 2022-04-08 View cached copy (2026-09-13)Live source ↗
Roles
Contiguous filings for the same role are collapsed into a single tenure span. Click a row to see the underlying filings.
| Company | Role | Tenure | Filings |
|---|---|---|---|
| Core Scientific | Chief Vision Officer, Director, 10%+ Owner | 2022-01 → present (4y 10mo) | 3 |
Show 3 underlying filings | |||
| Core Scientific | Director, 10%+ Owner | 2024-01 → present (2y 10mo) | 1 |
Insider transactions
Totals for this person
| Bucket | Invested (shares) | Invested (USD) | Divested (shares) | Divested (USD) | Net direction | Txns | Invested @ last price | Divested @ last price |
|---|---|---|---|---|---|---|---|---|
| All time | 51,416,542 | $0 | 69,555,574 | $18.31M | ↓ Divested $18.31M | 25 | $681.27M | $921.61M |
| 2024 | 51,416,542 | $0 | 63,555,574 | $0 | Flat | 20 | $681.27M | $842.11M |
| 2022 | - | $0 | 6,000,000 | $18.31M | ↓ Divested $18.31M | 5 | $0 | $79.50M |
| 2022-Q2 | - | $0 | 6,000,000 | $18.31M | ↓ Divested $18.31M | 5 | $0 | $79.50M |
| 2024-Q1 | 51,416,542 | $0 | 63,555,574 | $0 | Flat | 20 | $681.27M | $842.11M |
Invested = shares acquired (buys, grants, option exercises) — insider adding to the position. Divested = shares reduced (sells, dispositions, tax-withholding) — cash flowing TO the insider. Net direction shows which side wins on dollar terms in each bucket. % of holder's stake not yet computed (pending Form 3/4 holdings ingest). See methodology. The two @ last price columns restate the same share counts at the most recent share price we read (close of 2026-10-30); they are a valuation, not a cash flow, and they move every day the market does.
All transactions
| Date | Company | Kind | Shares | Amount (USD) | Value @ last price |
|---|---|---|---|---|---|
| 2024-01-23 | Core Scientific | Sale to issuer (buyback) · Common Stock, par value $0.0001 per share | 30,483,592 | - | $403.91M |
| 2024-01-23 | Core Scientific | Sale to issuer (buyback) · Common Stock, par value $0.0001 per share | 319,894 | - | $4.24M |
| 2024-01-23 | Core Scientific | Sale to issuer (buyback) · Common Stock, par value $0.0001 per share | 974,301 | - | $12.91M |
| 2024-01-23 | Core Scientific | Grant / award / vesting · Common Stock, par value $0.00001 per share | 3,048,359 | - | $40.39M |
| 2024-01-23 | Core Scientific | Grant / award / vesting · Common Stock, par value $0.00001 per share | 853,577 | - | $11.31M |
| 2024-01-23 | Core Scientific | Grant / award / vesting · Common Stock, par value $0.00001 per share | 31,989 | - | $423.9K |
| 2024-01-23 | Core Scientific | Grant / award / vesting · Common Stock, par value $0.00001 per share | 97,430 | - | $1.29M |
| 2024-01-23 | Core Scientific | Grant / award / vesting · Tranche 1 Warrants | 7,719,787 | - | $102.29M |
| 2024-01-23 | Core Scientific | Grant / award / vesting · Tranche 1 Warrants | 81,011 | - | $1.07M |
| 2024-01-23 | Core Scientific | Grant / award / vesting · Tranche 1 Warrants | 246,736 | - | $3.27M |
| 2024-01-23 | Core Scientific | Grant / award / vesting · Tranche 2 Warrants | 6,433,166 | - | $85.24M |
| 2024-01-23 | Core Scientific | Grant / award / vesting · Tranche 2 Warrants | 67,509 | - | $894.5K |
| 2024-01-23 | Core Scientific | Grant / award / vesting · Tranche 2 Warrants | 205,614 | - | $2.72M |
| 2024-01-23 | Core Scientific | Sale to issuer (buyback) · Common Stock, par value $0.0001 per share | 30,483,592 | - | $403.91M |
| 2024-01-23 | Core Scientific | Sale to issuer (buyback) · Common Stock, par value $0.0001 per share | 319,894 | - | $4.24M |
| 2024-01-23 | Core Scientific | Sale to issuer (buyback) · Common Stock, par value $0.0001 per share | 974,301 | - | $12.91M |
| 2024-01-23 | Core Scientific | Grant / award / vesting · Common Stock, par value $0.00001 per share | 30,483,592 | - | $403.91M |
| 2024-01-23 | Core Scientific | Grant / award / vesting · Common Stock, par value $0.00001 per share | 853,577 | - | $11.31M |
| 2024-01-23 | Core Scientific | Grant / award / vesting · Common Stock, par value $0.00001 per share | 319,894 | - | $4.24M |
| 2024-01-23 | Core Scientific | Grant / award / vesting · Common Stock, par value $0.00001 per share | 974,301 | - | $12.91M |
Show older transactions (5 more)
| Date | Company | Kind | Shares | Amount (USD) | Value @ last price |
|---|---|---|---|---|---|
| 2022-06-03 | Core Scientific | Open-market sale | 2,909,679 | $7,797,940 | $38.55M |
| 2022-06-02 | Core Scientific | Open-market sale | 500,000 | $1,535,000 | $6.62M |
| 2022-06-01 | Core Scientific | Open-market sale | 1,016,174 | $3,211,110 | $13.46M |
| 2022-05-31 | Core Scientific | Open-market sale | 1,124,147 | $4,103,137 | $14.89M |
| 2022-05-27 | Core Scientific | Open-market sale | 450,000 | $1,665,000 | $5.96M |